Market News AIOpen the app

Celularity Inc says it is back in line with Nasdaq's rules on stock price and value.

PaperworkRead the original at sec.gov
Neutral

Celularity told Nasdaq it regained compliance with minimum bid price and market value rules. It still has an outstanding deficiency for delayed SEC filings, so the story leaves the situation mixed.

CELU · Celularity Inc

AI read · Neutral

The AI's read

Celularity said Nasdaq confirmed it regained compliance with the minimum bid price and minimum market value listing rules. The filing also says a separate deficiency for delayed SEC filings remains outstanding and being worked on. Because two listing matters were closed but the reporting deficiency continues, this 8-K does not clearly improve or worsen Celularity's standing.

Get alerts for CELU

Follow Celularity Inc (CELU) free. When we publish a story about it, you get the plain-English explanation as an alert.

Get alerts for CELU
Free on the App Store and Google Play, or on the web.